Icahn gets at least one Biogen Idec seat, maybe more
This article was originally published in Scrip
Executive Summary
Biogen Idec's stockholders have elected at least one of activist investor Carl Icahn's nominees to its board, while the one remaining place on the board was "too close to call", the company said.